StockData
Pacira BioSciences, Inc. logo

Pacira BioSciences, Inc. (PCRX) stock

PCRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/3028% above fair value
$36.48+0.00 (0.00%)

Close on Nov 17, 2026Market cap $1.45BP/E 104.2Yield –

Pacira BioSciences operating margin

Operating margin is operating income as a percentage of revenue.

Pacira BioSciences's operating margin for the twelve months ending Jun 30, 2026 was 2.7%. For fiscal 2025 it was 2.6%, against -10.5% the year before. The highest annual figure on record is 16.6% in fiscal 2021.

Annual operating margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 20252.6%+13.1
FY2024Dec 31, 2024-10.5%−23.5
FY2023Dec 31, 202313.0%+4.0
FY2022Dec 31, 20229.0%−7.6
FY2021Dec 31, 202116.6%+5.8
FY2020Dec 31, 202010.8%+8.3
FY2019Dec 31, 20192.5%−2.2
FY2018Dec 31, 20184.7%+13.4
FY2017Dec 31, 2017-8.7%+2.9
FY2016Dec 31, 2016-11.6%−15.4
FY2015Dec 31, 20153.8%+6.4
FY2014Dec 31, 2014-2.6%+59.7
FY2013Dec 31, 2013-62.3%+63.8
FY2012Dec 31, 2012-126.1%+123.1
FY2011Dec 31, 2011-249.2%−93.3
FY2010Dec 31, 2010-155.9%+34.3
FY2009Dec 31, 2009-190.2%–

Quarterly operating margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q2 FY2026Jun 30, 20262.2%−2.5
Q1 FY2026Mar 31, 20263.9%+2.7
Q4 FY2025Dec 31, 20251.2%−12.0
Q3 FY2025Sep 30, 20253.5%+86.3
Q2 FY2025Jun 30, 20254.7%−11.2
Q1 FY2025Mar 31, 20251.2%−6.7
Q4 FY2024Dec 31, 202413.2%−5.1
Q3 FY2024Sep 30, 2024-82.8%−93.6
Q2 FY2024Jun 30, 202415.9%−7.7
Q1 FY2024Mar 31, 20247.9%+9.8
Q4 FY2023Dec 31, 202318.3%+24.1
Q3 FY2023Sep 30, 202310.8%−1.9
Q2 FY2023Jun 30, 202323.5%+5.1
Q1 FY2023Mar 31, 2023-1.9%−12.9
Q4 FY2022Dec 31, 2022-5.8%−8.4
Q3 FY2022Sep 30, 202212.7%−11.9
Q2 FY2022Jun 30, 202218.4%−7.3
Q1 FY2022Mar 31, 202211.0%−5.3
Q4 FY2021Dec 31, 20212.6%−11.7
Q3 FY2021Sep 30, 202124.6%+9.6
Q2 FY2021Jun 30, 202125.7%+35.2
Q1 FY2021Mar 31, 202116.3%+0.2
Q4 FY2020Dec 31, 202014.3%+12.9
Q3 FY2020Sep 30, 202015.0%+12.7
Q2 FY2020Jun 30, 2020-9.5%−14.6
Q1 FY2020Mar 31, 202016.2%+15.0
Q4 FY2019Dec 31, 20191.4%−11.5
Q3 FY2019Sep 30, 20192.3%−2.5
Q2 FY2019Jun 30, 20195.1%−2.6
Q1 FY2019Mar 31, 20191.2%+10.5
Q4 FY2018Dec 31, 201812.9%+2.2
Q3 FY2018Sep 30, 20184.9%+10.2
Q2 FY2018Jun 30, 20187.8%+30.0
Q1 FY2018Mar 31, 2018-9.3%+11.0
Q4 FY2017Dec 31, 201710.7%+14.1
Q3 FY2017Sep 30, 2017-5.3%+25.2
Q2 FY2017Jun 30, 2017-22.2%–
Q1 FY2017Mar 31, 2017-20.3%–
Q4 FY2016Dec 31, 2016-3.4%–
Q3 FY2016Sep 30, 2016-30.5%–

More Pacira BioSciences figures

See a number that looks wrong?